0.524
price down icon0.95%   -0.005
after-market Dopo l'orario di chiusura: .53 0.006 +1.15%
loading
Precedente Chiudi:
$0.529
Aprire:
$0.5051
Volume 24 ore:
779.07K
Relative Volume:
0.30
Capitalizzazione di mercato:
$21.81M
Reddito:
-
Utile/perdita netta:
$-74.56M
Rapporto P/E:
-0.2861
EPS:
-1.8316
Flusso di cassa netto:
$-60.27M
1 W Prestazione:
+15.24%
1M Prestazione:
+41.62%
6M Prestazione:
-40.45%
1 anno Prestazione:
-59.69%
Intervallo 1D:
Value
$0.49
$0.53
Intervallo di 1 settimana:
Value
$0.4201
$0.535
Portata 52W:
Value
$0.2201
$1.54

Rallybio Corp Stock (RLYB) Company Profile

Name
Nome
Rallybio Corp
Name
Telefono
203- 859-3820
Name
Indirizzo
234 CHURCH STREET, NEW HAVEN
Name
Dipendente
24
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
RLYB's Discussions on Twitter

Confronta RLYB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RLYB
Rallybio Corp
0.524 22.01M 0 -74.56M -60.27M -1.8316
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Rallybio Corp Stock (RLYB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-09 Downgrade H.C. Wainwright Buy → Neutral
2024-05-15 Downgrade JP Morgan Overweight → Neutral
2024-02-07 Downgrade Jefferies Buy → Hold
2023-04-17 Iniziato H.C. Wainwright Buy
2023-04-10 Iniziato Wedbush Outperform
2022-12-09 Iniziato JP Morgan Overweight
2022-02-22 Iniziato JMP Securities Mkt Outperform
2021-08-23 Iniziato Cowen Outperform
2021-08-23 Iniziato Evercore ISI Outperform
2021-08-23 Iniziato Jefferies Buy
Mostra tutto

Rallybio Corp Borsa (RLYB) Ultime notizie

pulisher
Jul 24, 2025

Should I buy Rallybio Corporation stock before earningsFastest-growing stock picks - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Rallybio’s RLYB116 Study: A Potential Game-Changer in Complement Inhibition - TipRanks

Jul 24, 2025
pulisher
Jul 23, 2025

Rallybio Corporation Stock Analysis and ForecastMassive profits - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Is Rallybio Corporation a good long term investmentSky-high profits - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Rallybio Corporation stockHigh-octane gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential Oral Therapy for Rare Bone Disorder Hypophosphatasia - MSN

Jul 22, 2025
pulisher
Jul 20, 2025

What drives Rallybio Corporation stock priceUnmatched market gains - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 19, 2025

Recursion to buy Rallybio’s ownership in jointly developed bone disorder drug - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

10 Best Small Cap AI Stocks to Buy According to Analysts - Insider Monkey

Jul 18, 2025
pulisher
Jul 17, 2025

Recursion Pharmaceuticals Rises 6% in a Month: How to Play the Stock - MSN

Jul 17, 2025
pulisher
Jul 16, 2025

Deal Watch: Debiopharm Takes On Precision Oncology Drug From Repare Collab - insights.citeline.com

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Rallybio Corporation stock price move sharplyFree Best Performing Stock Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Rallybio Corporation stock attracts strong analyst attentionFree Join Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Rallybio Corporation stock performs during market volatilityCarefully Curated High Return Stocks - Newser

Jul 15, 2025
pulisher
Jul 13, 2025

RXRX Stock Up on Acquiring Full Rights to the Hypophosphatasia Program - MSN

Jul 13, 2025
pulisher
Jul 11, 2025

Here's Why Shares in Recursion Pharmaceuticals Surged Today - MSN

Jul 11, 2025
pulisher
Jul 10, 2025

We're Keeping An Eye On Rallybio's (NASDAQ:RLYB) Cash Burn Rate - simplywall.st

Jul 10, 2025
pulisher
Jul 09, 2025

Recursion Pharmaceuticals (RXRX) Rallies 8.7% on Hypophosphatasia - Insider Monkey

Jul 09, 2025
pulisher
Jul 09, 2025

Rallybio to sell interest in REV102 to Recursion Pharmaceuticals for up to $25M - Yahoo Finance

Jul 09, 2025
pulisher
Jul 09, 2025

Rallybio sells REV102 programme to Recursion for up to $25m - Pharmaceutical Business review -

Jul 09, 2025
pulisher
Jul 09, 2025

Rallybio Drops 9.98% Despite Q1 Progress, Recursion Deal - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Rallybio sells HPP treatment program to Recursion for up to $25 million By Investing.com - Investing.com South Africa

Jul 09, 2025
pulisher
Jul 08, 2025

Rallybio sells HPP treatment program to Recursion for up to $25 million - Investing.com Nigeria

Jul 08, 2025
pulisher
Jul 08, 2025

Biotech Stocks Climb With Recursion's Bold Move Forward - Finimize

Jul 08, 2025
pulisher
Jul 08, 2025

Recursion Pharmaceuticals stock soars after acquiring HPP treatment from Rallybio - Investing.com India

Jul 08, 2025
pulisher
Jul 08, 2025

Recursion Pharmaceuticals Rises With Rallybio Acquisition Move - Finimize

Jul 08, 2025
pulisher
Jul 08, 2025

Recursion, Rallybio Shares Rise After Deal on Joint Hypophosphatasia Candidate - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals - citybiz

Jul 08, 2025
pulisher
Jul 08, 2025

RallyBio - Hartford Business Journal

Jul 08, 2025
pulisher
Jul 08, 2025

Rallybio sells interest in drug program in deal worth up to $25M - Hartford Business Journal

Jul 08, 2025
pulisher
Jul 08, 2025

Why Is Microcap Rallybio Stock Trading Higher On Tuesday? - Benzinga

Jul 08, 2025
pulisher
Jul 08, 2025

Rallybio Stock (RLYB) Rockets 25% on a Recursion Pharmaceuticals Agreement - TipRanks

Jul 08, 2025
pulisher
Jul 08, 2025

Rallybio shifts gears, cashing out of Recursion pact to extend runway - Fierce Biotech

Jul 08, 2025

Rallybio Corp Azioni (RLYB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):